Cushing's syndrome can be treated with numerous options including cognitive behavioral therapy and stress management programs

 


Cushing's syndrome, also known as cochlear damage, is a health condition wherein inner ear nerve endings become damaged. The inner ear is the part of the brain that houses the hearing nerve and enables humans to hear. The outer ear is the part of the body that is usually involved with balance and movement of the jaw. There are many causes of cochlear damage. Exposure to loud noises is one such cause. Other causes include traumatic brain injury, tumors within the head, and certain types of medicines. According to the National Organization for Rare Disorders (NORD), around 13 individuals per 1 million population suffer from endogenous Cushing's syndrome.

Treatment for Cushing's syndrome can vary depending on what kind of symptoms an individual exhibits. If the inner ear is not damaged although the patient is experiencing ringing in the ears, treatment for that will not be necessary. Treating the imbalance will allow the ears to function normally again. If the inner ear is damaged, treatment for the problem will be more complicated. Another treatment option is behavioral therapy. This works by changing the thoughts and behaviors to help change the behavior so that patient can better relate to others. In severe cases, medications may be prescribed. Antipsychotic drugs are commonly prescribed to treat symptoms of Cushing’s syndrome.

In addition to medication, other treatment options include therapies and behavioral modifications. Cognitive-behavioral therapy helps patients deal with their symptoms. Stress management programs can help individuals deal with symptoms of Cushing's syndrome. These usually involve setting daily goals and working to achieve them. Another effective method for relieving Cushing's symptoms is through cognitive behavior therapy. This technique teaches patients how to recognize their symptoms and what to do about them. Recently, in July 2020, Cortisol synthesis inhibitor osilodrostat named Istursia was made available as a medical treatment in Germany for Cushing's syndrome after receiving approval from European Commission in January 2020.

Comments

Popular posts from this blog

Increasing Initiatives to Digitalize the Healthcare Sector Is Expected To Boost Demand for Electronic Medical Records

Increase In Oil Production and Exploration Activities Is Creating a Need for Oilfield Chemicals

What are various pigmented lesions treatment available in market today?